Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy

20 Jul 2015

Abstract excerpt

// Jian Xu 1 , Xiu-Jun Liu 1 , Liang Li 1 , Sheng-Hua Zhang 1 , Yi Li 1 , Rui-Juan Gao 1 , Yong-Su Zhen 1 1 Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China Correspondence to: Yong-Su Zhen, e-mail: zhenysm@126.com Keywords: MMP-14, TIMP2, fusion protein, targeted therapeutics, antitumor efficacy Received: April 30, 2015 Accepted: July 08,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Peptidase Inhibition and Analysis
Share to Phytochemical compounds biological activities
Share to Signaling Pathways in Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26314845
DOI: 10.18632/oncotarget.4709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacyPMID 26314845Read ↗

Optimization strategies for expression of a novel bifunctional anti-PD-L1/TGFBR2-ECD fusion protein.Semantic proximity Read ↗

An albumin‑binding domain and targeting peptide‑based recombinant protein and its enediyne‑integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K‑ras mutation.Semantic proximity Read ↗

Gd–Metallofullerenol Nanomaterial Suppresses Pancreatic Cancer Metastasis by Inhibiting the Interaction of Histone Deacetylase 1 and Metastasis-Associated Protein 1Semantic proximity Read ↗

Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14Semantic proximity Read ↗

The Development of MetAP-2 Inhibitors in Cancer TreatmentSemantic proximity Read ↗

Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide ExtensionSemantic proximity Read ↗

Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancerSemantic proximity Read ↗

Bioactivity of Recombinant Humanized Monoclonal Antibody Against HER2 and Its Mechanism of Action on Ovarian CancerSemantic proximity Read ↗

Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.Semantic proximity Read ↗

A broad matrix metalloproteinase inhibitor with designed loop extension exhibits ultrahigh specificity for MMP-14Semantic proximity Read ↗

Effect of TIMPs and Their Minimally Engineered Variants in Blocking Invasion and Migration of Brain Cancer CellsSemantic proximity Read ↗

Structural characterization andin vivopro-tumor properties of a highly conserved matrikineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.